Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case

Metastasis of head and neck squamous cell carcinoma rarely occurs in hepatic cancer and has a poor prognosis (median survival of 4 months). The efficacy of immunotherapy for these patients remains unknown. Herein, we present a patient with hypopharyngeal carcinoma metastasis to the liver with TERT a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Taowei, Liang, Faya, Lin, Peiliang, Li, Yangyang, Huang, Xiaoming, Han, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746516/
https://www.ncbi.nlm.nih.gov/pubmed/35878084
http://dx.doi.org/10.1080/21645515.2022.2093075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746516/
https://www.ncbi.nlm.nih.gov/pubmed/35878084
http://dx.doi.org/10.1080/21645515.2022.2093075

Ejemplares similares